Mannucci, E. and Ghetti, G. 2022. Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy. Farmeconomia. Health economics and therapeutic pathways. 23, 1 (Dec. 2022). DOI:https://doi.org/10.7175/fe.v23i1.1539.